In this issue of Clinics in Chest Medicine, guest editors Drs. Clemente J. Britto and Jennifer L. Taylor-Cousar bring their considerable expertise to Advances in Cystic Fibrosis. Top experts in the field cover key topics such as genetics of cystic fibrosis (CF): clinical implications; innate and adaptive immunity in CF; novel applications of biomarkers and personalized medicine to define the spectrum of CF; emerging approaches to understand CF pathogenesis; and more.
Contains 18 relevant, practice-oriented topics including novel approaches to multidrug resistant infections in CF; clinical outcomes of highly-effective modulator therapy; nontuberculous mycobacterial infections in CF; management of mental health in CF; sexual and reproductive health in CF; nutritional management in CF; transitions of care in CF; and more.
Provides in-depth clinical reviews on advances in cystic fibrosis, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations - p. 579 9. Genetics of Cystic Fibrosis: Clinical Implications - p. 591 10. Update on Innate and Adaptive Immunity in Cystic Fibrosis - p. 603 11. Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis - p. 617 12. Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators - p. 631 13. The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation - p. 647 14. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis - p. 667 15. Update on Clinical Outcomes of Highly Effective Modulator Therapy - p. 677 16. Nontuberculous Mycobacterial Infections in Cystic Fibrosis - p. 697 17. Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient - p. 717 18. Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era - p. 727 19. Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis - p. 743 20. Transitions of Care in Cystic Fibrosis - p. 757 21. Endocrine Complications of Cystic Fibrosis - p. 773 22. Management of Mental Health in Cystic Fibrosis - p. 791 23. Family Planning and Reproductive Health in Cystic Fibrosis - p. 811 24. Update on Lung Transplantation for Cystic Fibrosis - p. 821
In this issue of Clinics in Chest Medicine, guest editors Drs. Clemente J. Britto and Jennifer L. Taylor-Cousar bring their considerable expertise to Advances in Cystic Fibrosis. Top experts in the field cover key topics such as genetics of cystic fibrosis (CF): clinical implications; innate and adaptive immunity in CF; novel applications of biomarkers and personalized medicine to define the spectrum of CF; emerging approaches to understand CF pathogenesis; and more.
Contains 18 relevant, practice-oriented topics including novel approaches to multidrug resistant infections in CF; clinical outcomes of highly-effective modulator therapy; nontuberculous mycobacterial infections in CF; management of mental health in CF; sexual and reproductive health in CF; nutritional management in CF; transitions of care in CF; and more.
Provides in-depth clinical reviews on advances in cystic fibrosis, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations - p. 579 9. Genetics of Cystic Fibrosis: Clinical Implications - p. 591 10. Update on Innate and Adaptive Immunity in Cystic Fibrosis - p. 603 11. Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis - p. 617 12. Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators - p. 631 13. The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation - p. 647 14. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis - p. 667 15. Update on Clinical Outcomes of Highly Effective Modulator Therapy - p. 677 16. Nontuberculous Mycobacterial Infections in Cystic Fibrosis - p. 697 17. Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient - p. 717 18. Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era - p. 727 19. Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis - p. 743 20. Transitions of Care in Cystic Fibrosis - p. 757 21. Endocrine Complications of Cystic Fibrosis - p. 773 22. Management of Mental Health in Cystic Fibrosis - p. 791 23. Family Planning and Reproductive Health in Cystic Fibrosis - p. 811 24. Update on Lung Transplantation for Cystic Fibrosis - p. 821
